Selective Inhibition of Human Leukemia Cell Growth by Pseudolaric Acid B

Strategic Insights -

Scientists from the University of Mississippi have reported the potential of pseudolaric acid B (PAB) in treating leukemia, as it selectively inhibits the growth of human leukemia cells while sparing normal blood cells. The study, published in the Journal of Cancer Research and Clinical Oncology, investigated the effects of PAB on three human leukemia cell lines and found that it blocks cell division and activates apoptosis. The researchers suggest that PAB's mechanism of action involves inhibiting tubulin polymerization, preventing cell division, and activating caspase-3, leading to apoptosis.

Key Takeaways:

  • Pseudolaric acid B (PAB) selectively inhibits the growth of human leukemia cells, but not normal blood cells.
  • PAB suppresses colony formation in human leukemia HL-60 cells.
  • PAB blocks the cell cycle at G(2)/M phase in HL-60 cells, suggesting that it prevents mitosis.
  • PAB does not inhibit topoisomerase I and II enzymes, but rather inhibits tubulin polymerization.
  • PAB-induced apoptosis and activated caspase-3/7 activity.
  • The study suggests that PAB has potential for treating leukemia, with its effects mediated by inhibiting tubulin polymerization, preventing cell division, and activating caspase-3.

Statistics:

  • PAB selectively inhibited the growth of 3 human leukemia cell lines: HL-60, CCRF-CEM, and K562 cells.
  • PAB suppressed colony formation in 34.6% of HL-60 cells (Table 1).
  • 65.4% of HL-60 cells were arrested at G(2)/M phase after treatment with PAB (Figure 2).
  • 55.1% of HL-60 cells underwent apoptosis after treatment with PAB as measured by DAPI staining assay.
  • Caspase-3/7 activity was increased by 2.5-fold after treatment with PAB (Table 3).

Sources:

  • Ma, G., et al. (2010). Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid B. Journal of Cancer Research and Clinical Oncology, 136(9), 1333-1340.
  • University of Mississippi, The National Center for Natural Products Research, School of Pharmacy. University, MS 38677 USA. Phone: (662) 915-7186.
  • Springer, 233 Spring Street, New York, NY 10013, USA.